Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP+/NADPH and the substrate folic acid
Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH‐dependent reduction of both conjugated (folate) and unconjugated (biopteri...
Saved in:
Published in | Acta crystallographica. Section F, Structural biology communications Vol. 78; no. 4; pp. 170 - 176 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
5 Abbey Square, Chester, Cheshire CH1 2HU, England
International Union of Crystallography
01.04.2022
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 2053-230X 2053-230X |
DOI | 10.1107/S2053230X22002795 |
Cover
Loading…
Abstract | Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH‐dependent reduction of both conjugated (folate) and unconjugated (biopterin) pterins to their tetrahydro forms, starting from oxidized‐ or dihydro‐state substrates. The currently available X‐ray structures of Leishmania major PTR1 (LmPTR1) show the enzyme in its unbound, unconjugated substrate‐bound (with biopterin derivatives) and inhibitor‐bound forms. However, no structure has yet been determined of LmPTR1 bound to a conjugated substrate. Here, the high‐resolution crystal structure of LmPTR1 in complex with folic acid is presented and the intermolecular forces that drive the binding of the substrate in the catalytic pocket are described. By expanding the collection of LmPTR1 structures in complex with process intermediates, additional insights into the active‐site rearrangements that occur during the catalytic process are provided. In contrast to previous structures with biopterin derivatives, a small but significant difference in the orientation of Asp181 and Tyr194 of the catalytic triad is found. This feature is shared by PTR1 from T. brucei (TbPTR1) in complex with the same substrate molecule and may be informative in deciphering the importance of such residues at the beginning of the catalytic process.
The high‐resolution structure of Leishmania major pteridine reductase 1 in complex with its cofactor NADP+/NADPH and its substrate folic acid is reported. It provides insight into the active‐site rearrangements that occur during the catalytic process. |
---|---|
AbstractList | Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera
Leishmania
and
Trypanosoma
and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH-dependent reduction of both conjugated (folate) and unconjugated (biopterin) pterins to their tetrahydro forms, starting from oxidized- or dihydro-state substrates. The currently available X-ray structures of
Leishmania major
PTR1 (
Lm
PTR1) show the enzyme in its unbound, unconjugated substrate-bound (with biopterin derivatives) and inhibitor-bound forms. However, no structure has yet been determined of
Lm
PTR1 bound to a conjugated substrate. Here, the high-resolution crystal structure of
Lm
PTR1 in complex with folic acid is presented and the intermolecular forces that drive the binding of the substrate in the catalytic pocket are described. By expanding the collection of
Lm
PTR1 structures in complex with process intermediates, additional insights into the active-site rearrangements that occur during the catalytic process are provided. In contrast to previous structures with biopterin derivatives, a small but significant difference in the orientation of Asp181 and Tyr194 of the catalytic triad is found. This feature is shared by PTR1 from
T. brucei
(
Tb
PTR1) in complex with the same substrate molecule and may be informative in deciphering the importance of such residues at the beginning of the catalytic process. Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH-dependent reduction of both conjugated (folate) and unconjugated (biopterin) pterins to their tetrahydro forms, starting from oxidized- or dihydro-state substrates. The currently available X-ray structures of Leishmania major PTR1 (LmPTR1) show the enzyme in its unbound, unconjugated substrate-bound (with biopterin derivatives) and inhibitor-bound forms. However, no structure has yet been determined of LmPTR1 bound to a conjugated substrate. Here, the high-resolution crystal structure of LmPTR1 in complex with folic acid is presented and the intermolecular forces that drive the binding of the substrate in the catalytic pocket are described. By expanding the collection of LmPTR1 structures in complex with process intermediates, additional insights into the active-site rearrangements that occur during the catalytic process are provided. In contrast to previous structures with biopterin derivatives, a small but significant difference in the orientation of Asp181 and Tyr194 of the catalytic triad is found. This feature is shared by PTR1 from T. brucei (TbPTR1) in complex with the same substrate molecule and may be informative in deciphering the importance of such residues at the beginning of the catalytic process.Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH-dependent reduction of both conjugated (folate) and unconjugated (biopterin) pterins to their tetrahydro forms, starting from oxidized- or dihydro-state substrates. The currently available X-ray structures of Leishmania major PTR1 (LmPTR1) show the enzyme in its unbound, unconjugated substrate-bound (with biopterin derivatives) and inhibitor-bound forms. However, no structure has yet been determined of LmPTR1 bound to a conjugated substrate. Here, the high-resolution crystal structure of LmPTR1 in complex with folic acid is presented and the intermolecular forces that drive the binding of the substrate in the catalytic pocket are described. By expanding the collection of LmPTR1 structures in complex with process intermediates, additional insights into the active-site rearrangements that occur during the catalytic process are provided. In contrast to previous structures with biopterin derivatives, a small but significant difference in the orientation of Asp181 and Tyr194 of the catalytic triad is found. This feature is shared by PTR1 from T. brucei (TbPTR1) in complex with the same substrate molecule and may be informative in deciphering the importance of such residues at the beginning of the catalytic process. Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH‐dependent reduction of both conjugated (folate) and unconjugated (biopterin) pterins to their tetrahydro forms, starting from oxidized‐ or dihydro‐state substrates. The currently available X‐ray structures of Leishmania major PTR1 (LmPTR1) show the enzyme in its unbound, unconjugated substrate‐bound (with biopterin derivatives) and inhibitor‐bound forms. However, no structure has yet been determined of LmPTR1 bound to a conjugated substrate. Here, the high‐resolution crystal structure of LmPTR1 in complex with folic acid is presented and the intermolecular forces that drive the binding of the substrate in the catalytic pocket are described. By expanding the collection of LmPTR1 structures in complex with process intermediates, additional insights into the active‐site rearrangements that occur during the catalytic process are provided. In contrast to previous structures with biopterin derivatives, a small but significant difference in the orientation of Asp181 and Tyr194 of the catalytic triad is found. This feature is shared by PTR1 from T. brucei (TbPTR1) in complex with the same substrate molecule and may be informative in deciphering the importance of such residues at the beginning of the catalytic process. The high‐resolution structure of Leishmania major pteridine reductase 1 in complex with its cofactor NADP+/NADPH and its substrate folic acid is reported. It provides insight into the active‐site rearrangements that occur during the catalytic process. Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH‐dependent reduction of both conjugated (folate) and unconjugated (biopterin) pterins to their tetrahydro forms, starting from oxidized‐ or dihydro‐state substrates. The currently available X‐ray structures of Leishmania major PTR1 (LmPTR1) show the enzyme in its unbound, unconjugated substrate‐bound (with biopterin derivatives) and inhibitor‐bound forms. However, no structure has yet been determined of LmPTR1 bound to a conjugated substrate. Here, the high‐resolution crystal structure of LmPTR1 in complex with folic acid is presented and the intermolecular forces that drive the binding of the substrate in the catalytic pocket are described. By expanding the collection of LmPTR1 structures in complex with process intermediates, additional insights into the active‐site rearrangements that occur during the catalytic process are provided. In contrast to previous structures with biopterin derivatives, a small but significant difference in the orientation of Asp181 and Tyr194 of the catalytic triad is found. This feature is shared by PTR1 from T. brucei (TbPTR1) in complex with the same substrate molecule and may be informative in deciphering the importance of such residues at the beginning of the catalytic process. The high-resolution structure of Leishmania major pteridine reductase 1 in complex with its cofactor NADP + /NADPH and its substrate folic acid is reported. It provides insight into the active-site rearrangements that occur during the catalytic process. Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug target for tropical diseases. This enzyme is able to catalyze the NADPH-dependent reduction of both conjugated (folate) and unconjugated (biopterin) pterins to their tetrahydro forms, starting from oxidized- or dihydro-state substrates. The currently available X-ray structures of Leishmania major PTR1 ( Lm PTR1) show the enzyme in its unbound, unconjugated substrate-bound (with biopterin derivatives) and inhibitor-bound forms. However, no structure has yet been determined of Lm PTR1 bound to a conjugated substrate. Here, the high-resolution crystal structure of Lm PTR1 in complex with folic acid is presented and the intermolecular forces that drive the binding of the substrate in the catalytic pocket are described. By expanding the collection of Lm PTR1 structures in complex with process intermediates, additional insights into the active-site rearrangements that occur during the catalytic process are provided. In contrast to previous structures with biopterin derivatives, a small but significant difference in the orientation of Asp181 and Tyr194 of the catalytic triad is found. This feature is shared by PTR1 from T. brucei ( Tb PTR1) in complex with the same substrate molecule and may be informative in deciphering the importance of such residues at the beginning of the catalytic process. |
Author | Di Pisa, Flavio Dello Iacono, Lucia Mangani, Stefano |
Author_xml | – sequence: 1 givenname: Lucia surname: Dello Iacono fullname: Dello Iacono, Lucia organization: University of Siena – sequence: 2 givenname: Flavio surname: Di Pisa fullname: Di Pisa, Flavio organization: University of Siena – sequence: 3 givenname: Stefano surname: Mangani fullname: Mangani, Stefano email: stefano.mangani@unisi.it organization: University of Siena |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35400669$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9qFDEUxgep2Fr7AN5IwBtBts3_zNwI62pbYamCFfRqyGZO3Cwzk22Sse5D-M5mdttSK-hNEs75fd85J8nTYq_3PRTFc4KPCcHq5DPFglGGv1KKMVWVeFQcjKHJGNu7d94vjmJcYYxHGVHVk2KfCY6xlNVB8WsWNjHpFsUUBpOGAMhblJaAEoRehw0yvlu38HMMz8HFZad7p1GnVz6gdYZc43pAAZos1xEQQdcuLbcWxlttUuYupu8-vT4Z13Ok-2abjMMi19QJkPWtM0gb1zwrHlvdRji62Q-LL6fvL2fnk_nHsw-z6XxiuFJywjW3Aiom8hClwKUSSi2kpJZbJqSljPESOG8UkDKHSlkRaxZaYEEZMCHYYfFm57seFh00BvrcSVuvg-vyyLXXrv4z07tl_d3_qMuqkoSX2eDVjUHwVwPEVHcuGmhb3YMfYk0lr6jIfdCMvnyArvyQr7bdUmVFs53M1Iv7Hd21cvtSGSA7wAQfYwB7hxBcjy9b__UhskY90BiXdHJ-HMq1_1RWO-W1a2Hz_1L19NspvXwriJLsN0pDyLw |
CitedBy_id | crossref_primary_10_1002_med_22005 crossref_primary_10_1371_journal_pntd_0011458 crossref_primary_10_1007_s00249_023_01677_6 crossref_primary_10_3390_agronomy13112765 crossref_primary_10_1016_j_bioorg_2022_106062 crossref_primary_10_1093_jb_mvad062 crossref_primary_10_3390_ph18010006 crossref_primary_10_1016_j_ejmech_2022_114959 crossref_primary_10_1016_j_ejmech_2025_117392 crossref_primary_10_1016_j_ejmech_2023_115534 crossref_primary_10_3390_pathogens12010136 |
Cites_doi | 10.1016/0166-6851(90)90147-E 10.1107/S0907444910045749 10.1038/88584 10.1099/00221287-18-3-621 10.1021/acs.jmedchem.8b02021 10.1073/pnas.91.24.11442 10.1107/S0907444909042589 10.1107/S0907444911007281 10.1016/0166-6851(84)90117-8 10.1107/S0907444912001308 10.1021/jm901059x 10.1017/S0031182097001133 10.1107/S2059798319011471 10.1107/S0907444910040886 10.1046/j.1432-1327.1998.2510768.x 10.1107/S0907444910007493 10.3390/tropicalmed2030036 10.1038/msb.2011.75 10.1021/bi972693a 10.1038/nprot.2008.91 10.1016/j.jmb.2007.05.022 10.1074/jbc.272.21.13883 10.1107/S0907444905036693 10.1093/nar/gku316 10.3390/molecules22030426 10.1021/acsomega.7b00473 10.1107/S0907444905039107 10.1016/j.jmb.2005.06.076 10.1021/acs.jmedchem.6b00698 10.1177/1087057114555846 10.1107/S0907444909042073 10.1016/S0968-0004(97)01140-7 10.1006/expr.1997.4207 |
ContentType | Journal Article |
Copyright | 2022 Lucia Dello Iacono et al. published by IUCr Journals. open access. 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Lucia Dello Iacono et al. 2022 2022 |
Copyright_xml | – notice: 2022 Lucia Dello Iacono et al. published by IUCr Journals. – notice: open access. – notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Lucia Dello Iacono et al. 2022 2022 |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T7 7TM 7U9 8FD C1K FR3 H94 M7N P64 7X8 5PM |
DOI | 10.1107/S2053230X22002795 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Virology and AIDS Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Pteridine reductase |
EISSN | 2053-230X |
EndPage | 176 |
ExternalDocumentID | PMC8996148 35400669 10_1107_S2053230X22002795 AYF2TB5176 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Seventh Framework Programme grantid: 603240 |
GroupedDBID | 0R~ 1OC 24P 33P 3SF 52U 53G 5VS AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAXRX AAYCA AAZKR ABCUV ABPVW ACAHQ ACCFJ ACCZN ACGFS ACPOU ACRPL ACXBN ACXQS ACYXJ ADBBV ADEOM ADIYS ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB AOIJS ATUGU AUFTA AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BRXPI BY8 DCZOG DIK DRFUL DRSTM EBS EJD G-S GODZA H.T H.X HGLYW HH5 HYE J0M LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM O66 P2W RCJ RPM SUPJJ W99 WBFHL WBKPD WIH WIK WOHZO WYISQ ZZTAW AAYXX ABJNI AEYWJ AGHNM AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QL 7T7 7TM 7U9 8FD C1K FR3 H94 M7N P64 7X8 5PM |
ID | FETCH-LOGICAL-c4776-4a4f5e93500685087577b662f4f356f23348e44d7e184f38691fcba50523e3553 |
IEDL.DBID | 24P |
ISSN | 2053-230X |
IngestDate | Thu Aug 21 18:30:01 EDT 2025 Thu Jul 10 22:59:12 EDT 2025 Fri Jul 25 12:11:56 EDT 2025 Mon Jul 21 05:46:12 EDT 2025 Thu Apr 24 23:09:33 EDT 2025 Tue Jul 01 01:18:28 EDT 2025 Wed Jan 22 16:25:18 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | pteridine reductase catalysis cofactors folic acid Leishmania major |
Language | English |
License | Attribution open access. This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4776-4a4f5e93500685087577b662f4f356f23348e44d7e184f38691fcba50523e3553 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2867-283X 0000-0003-4824-7478 0000-0003-2302-1464 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1107%2FS2053230X22002795 |
PMID | 35400669 |
PQID | 2648924836 |
PQPubID | 1036388 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8996148 proquest_miscellaneous_2649253342 proquest_journals_2648924836 pubmed_primary_35400669 crossref_primary_10_1107_S2053230X22002795 crossref_citationtrail_10_1107_S2053230X22002795 wiley_primary_10_1107_S2053230X22002795_AYF2TB5176 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2022 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: April 2022 |
PublicationDecade | 2020 |
PublicationPlace | 5 Abbey Square, Chester, Cheshire CH1 2HU, England |
PublicationPlace_xml | – name: 5 Abbey Square, Chester, Cheshire CH1 2HU, England – name: United States – name: Chester |
PublicationTitle | Acta crystallographica. Section F, Structural biology communications |
PublicationTitleAlternate | Acta Crystallogr F Struct Biol Commun |
PublicationYear | 2022 |
Publisher | International Union of Crystallography Wiley Subscription Services, Inc |
Publisher_xml | – name: International Union of Crystallography – name: Wiley Subscription Services, Inc |
References | Beck (tb5176_bb4) 1990; 43 Di Pisa (tb5176_bb10) 2017; 22 Robert (tb5176_bb29) 2014; 42 Annang (tb5176_bb3) 2015; 20 Linciano (tb5176_bb23) 2019; 62 Schüttelkopf (tb5176_bb31) 2005; 352 Mitra (tb5176_bb26) 2017; 2 McNicholas (tb5176_bb25) 2011; 67 Nare (tb5176_bb28) 1997; 272 Chen (tb5176_bb7) 2010; 66 Gourley (tb5176_bb13) 2001; 8 Dawson (tb5176_bb9) 2010; 66 Leblanc (tb5176_bb20) 1998; 251 Liebschner (tb5176_bb1) 2019; 75 Evans (tb5176_bb12) 2006; 62 Borsari (tb5176_bb6) 2016; 59 Hardy (tb5176_bb15) 1997; 87 Linciano (tb5176_bb22) 2017; 2 Winn (tb5176_bb8) 2011; 67 Luba (tb5176_bb24) 1998; 37 Bello (tb5176_bb5) 1994; 91 Langer (tb5176_bb18) 2008; 3 Nare (tb5176_bb27) 1997; 114 Afonine (tb5176_bb2) 2012; 68 Emsley (tb5176_bb11) 2010; 66 Leslie (tb5176_bb21) 2006; 62 Laskowski (tb5176_bb19) 1997; 22 Hammond (tb5176_bb14) 1984; 13 Vagin (tb5176_bb34) 2010; 66 Sievers (tb5176_bb32) 2011; 7 Krissinel (tb5176_bb17) 2007; 372 Kidder (tb5176_bb16) 1958; 18 Tulloch (tb5176_bb33) 2010; 53 |
References_xml | – volume: 43 start-page: 221 year: 1990 ident: tb5176_bb4 publication-title: Mol. Biochem. Parasitol. doi: 10.1016/0166-6851(90)90147-E – volume: 67 start-page: 235 year: 2011 ident: tb5176_bb8 publication-title: Acta Cryst. D doi: 10.1107/S0907444910045749 – volume: 8 start-page: 521 year: 2001 ident: tb5176_bb13 publication-title: Nat. Struct. Biol. doi: 10.1038/88584 – volume: 18 start-page: 621 year: 1958 ident: tb5176_bb16 publication-title: J. Gen. Microbiol. doi: 10.1099/00221287-18-3-621 – volume: 62 start-page: 3989 year: 2019 ident: tb5176_bb23 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.8b02021 – volume: 91 start-page: 11442 year: 1994 ident: tb5176_bb5 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.91.24.11442 – volume: 66 start-page: 22 year: 2010 ident: tb5176_bb34 publication-title: Acta Cryst. D doi: 10.1107/S0907444909042589 – volume: 67 start-page: 386 year: 2011 ident: tb5176_bb25 publication-title: Acta Cryst. D doi: 10.1107/S0907444911007281 – volume: 13 start-page: 243 year: 1984 ident: tb5176_bb14 publication-title: Mol. Biochem. Parasitol. doi: 10.1016/0166-6851(84)90117-8 – volume: 68 start-page: 352 year: 2012 ident: tb5176_bb2 publication-title: Acta Cryst. D doi: 10.1107/S0907444912001308 – volume: 53 start-page: 221 year: 2010 ident: tb5176_bb33 publication-title: J. Med. Chem. doi: 10.1021/jm901059x – volume: 114 start-page: S101 year: 1997 ident: tb5176_bb27 publication-title: Parasitology doi: 10.1017/S0031182097001133 – volume: 75 start-page: 861 year: 2019 ident: tb5176_bb1 publication-title: Acta Cryst. D doi: 10.1107/S2059798319011471 – volume: 66 start-page: 1334 year: 2010 ident: tb5176_bb9 publication-title: Acta Cryst. D doi: 10.1107/S0907444910040886 – volume: 251 start-page: 768 year: 1998 ident: tb5176_bb20 publication-title: Eur. J. Biochem. doi: 10.1046/j.1432-1327.1998.2510768.x – volume: 66 start-page: 486 year: 2010 ident: tb5176_bb11 publication-title: Acta Cryst. D doi: 10.1107/S0907444910007493 – volume: 2 start-page: 36 year: 2017 ident: tb5176_bb26 publication-title: Trop. Med. Infect. Dis. doi: 10.3390/tropicalmed2030036 – volume: 7 start-page: 539 year: 2011 ident: tb5176_bb32 publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2011.75 – volume: 37 start-page: 4093 year: 1998 ident: tb5176_bb24 publication-title: Biochemistry doi: 10.1021/bi972693a – volume: 3 start-page: 1171 year: 2008 ident: tb5176_bb18 publication-title: Nat. Protoc. doi: 10.1038/nprot.2008.91 – volume: 372 start-page: 774 year: 2007 ident: tb5176_bb17 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2007.05.022 – volume: 272 start-page: 13883 year: 1997 ident: tb5176_bb28 publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.21.13883 – volume: 62 start-page: 72 year: 2006 ident: tb5176_bb12 publication-title: Acta Cryst. D doi: 10.1107/S0907444905036693 – volume: 42 start-page: W320 year: 2014 ident: tb5176_bb29 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gku316 – volume: 22 start-page: 426 year: 2017 ident: tb5176_bb10 publication-title: Molecules doi: 10.3390/molecules22030426 – volume: 2 start-page: 5666 year: 2017 ident: tb5176_bb22 publication-title: ACS Omega doi: 10.1021/acsomega.7b00473 – volume: 62 start-page: 48 year: 2006 ident: tb5176_bb21 publication-title: Acta Cryst. D doi: 10.1107/S0907444905039107 – volume: 352 start-page: 105 year: 2005 ident: tb5176_bb31 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2005.06.076 – volume: 59 start-page: 7598 year: 2016 ident: tb5176_bb6 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b00698 – volume: 20 start-page: 82 year: 2015 ident: tb5176_bb3 publication-title: J. Biomol. Screen. doi: 10.1177/1087057114555846 – volume: 66 start-page: 12 year: 2010 ident: tb5176_bb7 publication-title: Acta Cryst. D doi: 10.1107/S0907444909042073 – volume: 22 start-page: 488 year: 1997 ident: tb5176_bb19 publication-title: Trends Biochem. Sci. doi: 10.1016/S0968-0004(97)01140-7 – volume: 87 start-page: 157 year: 1997 ident: tb5176_bb15 publication-title: Exp. Parasitol. doi: 10.1006/expr.1997.4207 |
SSID | ssj0001107179 |
Score | 2.3121254 |
Snippet | Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug... Pteridine reductase 1 (PTR1) is a key enzyme of the folate pathway in protozoan parasites of the genera Leishmania and Trypanosoma and is a valuable drug... The high-resolution structure of Leishmania major pteridine reductase 1 in complex with its cofactor NADP + /NADPH and its substrate folic acid is reported. It... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 170 |
SubjectTerms | Biopterins - metabolism catalysis cofactors Crystal structure Crystallography, X-Ray Enzymes Folic acid Folic Acid - chemistry Folic Acid - metabolism Intermediates Intermolecular forces Leishmania major Leishmania major - metabolism NADP NADP - metabolism Oxidoreductases Parasites pteridine reductase Pteridine reductase 1 Reductases Research Communications Substrate inhibition Substrates Therapeutic targets |
Title | Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP+/NADPH and the substrate folic acid |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1107%2FS2053230X22002795 https://www.ncbi.nlm.nih.gov/pubmed/35400669 https://www.proquest.com/docview/2648924836 https://www.proquest.com/docview/2649253342 https://pubmed.ncbi.nlm.nih.gov/PMC8996148 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qffFFFL-itazgkxJ62c_k8Tw9DpFSsIXzKWyyu_SkTUquBftH9H_uzCYXPQ4UfMlDdjchmZ3d38zO_AbgPXcVmlxoqVqdu1QK6dMqCJ_WWkhXZ5nJXIy2ONaLM_l1qZZ7MNvkwvT8EKPDjTQjrtek4LYaqpDEc_3vnIoaiMmSU5yBKdQDeEgptlS_gcuT346WjEwWgsE0IKURw-kmNhztPGV7f9oBnbuxk39i2rgpzZ_A4wFNsmkv_qew55tncDfrbhHzXbCeG_am86wNDIEei86_7pbFOHL_i25_86v1OXFgWHZpf7YduyLyZtzQPOuI1fUadzmWMXLXxkfUbV-hhx1PP598PKLrgtnGxcY1rkKR7ZYFohtmtl6553A2_3I6W6RD1YW0lsboVFoZlC-EouwRFQnvTaU1DzIIpQOn1F0vpTMejcMgcl1koa4sFcQTHtGLeAH7Tdv4V8CKyimPgBFRYZBUGMsWtc-1Krwzk5rnCUw2_7qsB0pyqoxxUUbTZGLKHfEk8GEcctXzcfyt88FGgOWgmuuSQvrQ6MyFTuDd2IxKRScltvHtTexTcEpS5gm87OU9vo0cZYjTigTM1kwYOxBh93ZLszqPxN1o2xLvagI8zpl_f0A5_THnp59UZvTr_xn0Bh5xSteIkUYHsI_Tzr9FEHVdHUYlOYzerXtWCA9X |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6N8QAvCMSvwAAj8QSK1tiOnTyWjapAqSbRSeUpcmJb6zSSKd0k9kfwP3PnpIGqEki85CG2EyXns787330H8IbbEk0utFSNymwshXRx6YWLKyWkrZJEJzZEW8zV9FR-WqbLPTje5MJ0_BCDw400I6zXpODkkO60PBzsf-VU1UCMlpwCDXSe3oLbEvE5BfZxefLb05KQzUI4mAbENKI_3sSGw52nbG9QO6hzN3jyT1AbdqXJfbjXw0k27uT_APZc_RB-HrU3CPouWEcOe9061niGSI8F7197w0IguftBt2dutT4jEgzDvpvzpmWXxN6MO5pjLdG6XuE2xxJG_trwiKrpSvSw-fj45N0hXafM1DY0rnEZCnS3zBPfMDPVyj6C08mHxdE07ssuxJXUWsXSSJ-6XKSUPpIGxntdKsW99CJVnlPurpPSaofWoReZyhNflYYq4gmH8EU8hv26qd1TYHlpU4eIEWGhl1QZy-SVy1SaO6tHFc8iGG3-dVH1nORUGuOiCLbJSBc74ong7TDksiPk-Fvng40Ai1431wXF9KHVmQkVweuhGbWKjkpM7Zrr0CfnlKXMI3jSyXt4G3nKEKjlEeitmTB0IMbu7ZZ6dRaYu9G4JeLVCHiYM__-gGL8bcIX79NEq2f_M-gV3JkuvsyK2cf55-dwl1PuRgg7OoB9nILuBSKqq_JlUJhfsqoRug |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFD6sK4gvoniLrjqCT0rYZq7JY-1aqi6l4C7UpzCZC1tZk5Lugvsj_M_OmaTRUlDwJQ-ZmYRk5sx85_YdgDfUVkHlCpqqlrlNOeMurTxzqZGMW5NlKrMx2mIuZ-f801IsD2CyzYXp-CEGgxtKRtyvUcDX1ndCHv36XygWNWCjJcU4A1WIW3AbnX4onZQvfhtaMlRZEAbjgBRH9N7N0HC895Td82kPdO7HTv6JaeOhNL0P93o0Scbd9D-AA1c_hJ-T9iZgvkvSccNet440ngSgR6Lxr70hMY7c_cDbp261uUAODE2-629NS9ZI3hwONEdaZHW9CqccyQiaa-MjTNNV6CHz8cni3TFeZ0TXNjZuwi4U2W6JR7phos3KPoLz6YezySztqy6khislU665F65gArNHRCS8V5WU1HPPhPQUU3cd51a5oBx6lssi86bSWBCPuYBe2GM4rJvaPQVSVFa4ABgDKvQcC2PpwrhcisJZNTI0T2C0_del6SnJsTLGZRlVk5Eq96YngbfDkHXHx_G3zkfbCSx70dyUGNIXlM6cyQReD81BqNBTomvXXMc-BcUkZZrAk26-h7ehoSzgtCIBtbMShg5I2L3bUq8uInF30G2RdzUBGtfMvz-gHH-d0rP3IlPy2f8MegV3FifT8vTj_PNzuEsxcyMGHR3BYViB7kXAU1fVyygvvwDi3hDj |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Crystal+structure+of+the+ternary+complex+of+Leishmania+major+pteridine+reductase+1+with+the+cofactor+NADP%2B%2FNADPH+and+the+substrate+folic+acid&rft.jtitle=Acta+crystallographica.+Section+F%2C+Structural+biology+communications&rft.au=Dello+Iacono%2C+Lucia&rft.au=Di+Pisa%2C+Flavio&rft.au=Mangani%2C+Stefano&rft.date=2022-04-01&rft.pub=International+Union+of+Crystallography&rft.eissn=2053-230X&rft.volume=78&rft.issue=Pt+4&rft.spage=170&rft.epage=176&rft_id=info:doi/10.1107%2FS2053230X22002795&rft_id=info%3Apmid%2F35400669&rft.externalDocID=PMC8996148 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2053-230X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2053-230X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2053-230X&client=summon |